Theravance Biopharma Inc (TBPH) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Theravance Biopharma Inc, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 8.89x | -8.15x | -11.26x | 0.95x | -3.85x | -3.98x |
| P/B Ratio | 3.17x | 2.62x | 2.92x | 1.87x | -2.27x | -3.65x |
| P/S Ratio | 8.76x | 7.14x | 10.82x | 16.08x | 13.88x | 15.42x |
| Profitability | ||||||
| Gross Margin | 94.9% | 100.0% | 29.3% | -23.5% | -250.1% | 100.0% |
| Operating Margin | -12.3% | -72.9% | -97.6% | -179.1% | -466.1% | -414.2% |
| Net Margin | 98.5% | -87.6% | -96.1% | 1698.5% | -360.6% | -386.9% |
| EBITDA Margin | -7.2% | -59.7% | -89.9% | -148.2% | -420.9% | -400.6% |
| Liquidity | ||||||
| Current Ratio | 10.93x | 5.02x | 5.39x | 12.31x | 4.26x | 3.18x |
| Quick Ratio | 10.93x | 5.02x | 5.39x | 12.31x | 4.26x | 3.18x |
| Leverage | ||||||
| Debt/Equity | 0.25x | 0.28x | 0.23x | 0.12x | -1.98x | -2.23x |
YoY = year-over-year change. Source: FMP..